Hussman Strategic Advisors’s Zimmer Biomet ZBH Stock Holding History

Hussman Strategic Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-51,500	Closed	-$5.88M	–	212
2015 Q1	$5.88M	Buy	+51,500	New	+$5.88M	0.62%	68
2013 Q4	–	Sell	-57,680	Closed	-$4.6M	–	229
2013 Q3	$4.6M	Sell	57,680 -148,320	-72%	-$11.7M	0.25%	105
2013 Q2	$15M	Buy	+206,000	New	+$15.4M	0.68%	75

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hussman Strategic Advisors's ZBH Position: Q2 2015 in Review

Hussman Strategic Advisors sold out of Zimmer Biomet (ZBH) in Q2 2015, closing a stake of 51,500 shares — an estimated $5.88M sold.

Hussman Strategic Advisors first reported a position in ZBH in Q2 2013 and held it in 3 quarters. The position peaked at $15M in Q2 2013. 749 funds tracked by Wall St. Rank hold ZBH as of Q2 2015.

Hussman Strategic Advisors reported no remaining Zimmer Biomet position as of Q2 2015 after selling out during the quarter.
Hussman Strategic Advisors sold 51,500 Zimmer Biomet shares in Q2 2015, an estimated $5.88M.
Hussman Strategic Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 3 quarters.
Hussman Strategic Advisors's Zimmer Biomet position peaked at $15M in Q2 2013.
749 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2015.

Based on Hussman Strategic Advisors's 13F filing for Q2 2015, filed 31 Jul 2015.